AOD-9604 Blood Tests & Monitoring AOD-9604 is usually discussed in a fat-loss and metabolic research context
Studies show GSNO administration increases wound collagen content by 52.0% at day 5 and 47.5% at day 10 compared to controls, while maintaining physiological collagenolytic activity necessary for proper tissue remodeling
It exists in every single cell of your body and is essential for: Neutralizing free radicals protecting DNA and mitochondria from damage
Norregaard PK, Deryabina MA, Tofteng Shelton P, et al
Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, et al
ClinicalTrials.gov lists 3 ongoing or completed trials (accessed February 12, 2026): NCT05239615 (topical for photoaging, Phase II, completed 2024, no results posted) [12]